Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News

Lonza Gets US$9.5m US Contract  



Lonza Gets US$9.5m US Contract 

October 10, 2012 - (Lonza) - "The National Institutes of Health Center for Regenerative Medicine (NIH CRM) has awarded Lonza Walkersville, Inc. a contract to generate induced pluripotent stem cells (iPSCs) under current Good Manufacturing Practices (cGMP).  The production of clinical grade iPSCs is considered a critical component to realizing the therapeutic potential of pluripotent stem cells. The contract also includes manufacturing of clinical grade iPSC-derived cell types."  Read Full Article


Posted on 18-Oct-12 by Gallerno, Jacob
Tags: Science and Industry News
Trackback Url  |  Link to this post | Bookmark this post with: